Status: Recruiting
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
A Phase 1 study to assess the safety and efficacy of OCU200 for center-involved diabetic macular edema
Participants needed: 24
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: OcugenUpdated: Dec 3, 2025Locations: 5
Eligibility criteria
Diagnosis of Type 1 or Type 2 Diabetes Mellitus [+6]
Presence of any condition that prevent clear visualization of retina (e.g., sign... [+10]